Cargando…
Tailored design of NKT-stimulatory glycolipids for polarization of immune responses
Natural killer T (NKT) cell is a distinct population of T lymphocytes that can rapidly release massive amount of Th1 and Th2 cytokines upon the engagement of their T cell receptor with glycolipids presented by CD1d. The secreted cytokines can promote cell-mediated immunity to kill tumor cells and in...
Autores principales: | Hung, Jung-Tung, Huang, Jing-Rong, Yu, Alice L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364570/ https://www.ncbi.nlm.nih.gov/pubmed/28335781 http://dx.doi.org/10.1186/s12929-017-0325-0 |
Ejemplares similares
-
First-in-human clinical trial of the NKT cell-stimulatory glycolipid OCH in multiple sclerosis
por: Sato, Wakiro, et al.
Publicado: (2023) -
Invariant NKT cells recognize glycolipids from pathogenic Gram-positive bacteria
por: Kinjo, Yuki, et al.
Publicado: (2011) -
NKT cell-dependent glycolipid–peptide vaccines with potent anti-tumour activity
por: Anderson, Regan J., et al.
Publicado: (2015) -
22511 Glycolipid-loaded nanoparticles harness iNKT cells for tumor immunotherapy
por: Shute, Travis, et al.
Publicado: (2021) -
A Rapid Fluorescence-Based Assay for Classification of iNKT Cell Activating Glycolipids
por: Arora, Pooja, et al.
Publicado: (2011)